- DuPont completed divestiture of its Aramids business, including Kevlar and Nomex, to Arclin in a deal valuing business at about $1.8 billion.
- Transaction delivered about $1.2 billion in cash proceeds.
- DuPont also received a $300 million note receivable.
- Non-controlling equity interest in Arclin was valued at $325 million, representing about a 16% stake.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DuPont de Nemours Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: PH24108) on April 01, 2026, and is solely responsible for the information contained therein.
Comments